We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

151 hedge funds and large institutions have $578M invested in Array Biopharma Inc in 2015 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 45 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 45

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less funds holding

Funds holding: 157 → 151 (-6)

11% less capital invested

Capital invested by funds: $653M → $578M (-$75M)

18% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 28

44% less call options, than puts

Call options by funds: $6.85M | Put options by funds: $12.2M

Holders
151
Holders Change
-6
Holders Change %
-3.82%
% of All Funds
3.96%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
23
Increased
48
Reduced
45
Closed
28
Calls
$6.85M
Puts
$12.2M
Net Calls
-$5.33M
Net Calls Change
-$7.65M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$11.1M
2
Renaissance Technologies
Renaissance Technologies
New York
+$10.4M
3
VAM
Visium Asset Management
New York
+$9.08M
4
OAM
Oxford Asset Management
United Kingdom
+$4.86M
5
TA
Teachers Advisors
New York
+$4.77M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$23.5M
2
TCM
TimesSquare Capital Management
New York
-$16.6M
3
BI
BVF Inc
California
-$13.7M
4
Invesco
Invesco
Georgia
-$10.5M
5
State Street
State Street
Massachusetts
-$7.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
Sarissa Capital Management
Connecticut
$2.95M +$3.19M +700,000 New
CCI
27
Columbus Circle Investors
$2.94M -$985K -215,786 -24%
Goldman Sachs
28
Goldman Sachs
New York
$2.91M -$1.76M -386,144 -36%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$2.64M -$122K -26,819 -4%
RCMC
30
Rubric Capital Management (Connecticut)
Connecticut
$2.53M +$2.74M +600,000 New
Parallax Volatility Advisers
31
Parallax Volatility Advisers
California
$2.49M +$2.43M +531,386 +900%
ARTA
32
A.R.T. Advisors
New York
$2.3M +$1.7M +373,110 +218%
FLAM
33
First Light Asset Management
Minnesota
$2.24M -$2.09M -458,198 -46%
Connor, Clark & Lunn Investment Management (CC&L)
34
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.2M -$970K -212,600 -29%
Principal Financial Group
35
Principal Financial Group
Iowa
$2.18M -$64 -14 -0%
Charles Schwab
36
Charles Schwab
California
$2.1M -$55.6K -12,192 -2%
BIM
37
BlackRock Investment Management
Delaware
$2.02M -$260 -57 -0%
Citadel Advisors
38
Citadel Advisors
Florida
$1.91M +$1.17M +256,897 +131%
TCIM
39
TIAA CREF Investment Management
New York
$1.9M -$64.4K -14,103 -3%
HCM
40
Highbridge Capital Management
New York
$1.61M +$1.74M +382,318 New
KIA
41
Kopp Investment Advisors
Minnesota
$1.59M -$24.2K -5,300 -1%
Two Sigma Advisers
42
Two Sigma Advisers
New York
$1.57M -$87.6K -19,200 -5%
RPAM
43
Rhenman & Partners Asset Management
Sweden
$1.56M – – –
Wells Fargo
44
Wells Fargo
California
$1.4M +$217K +47,510 +17%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$1.37M – – –
UBS Group
46
UBS Group
Switzerland
$1.28M +$1.05M +230,588 +321%
Los Angeles Capital Management
47
Los Angeles Capital Management
California
$1.19M +$1.21M +265,080 +1,684%
State of New Jersey Common Pension Fund D
48
State of New Jersey Common Pension Fund D
New Jersey
$1.12M – – –
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$1.1M +$21.4K +4,700 +2%
WMSA
50
Weiss Multi-Strategy Advisers
New York
$1.01M +$45.6K +10,000 +4%
1
2
3 4 5

ARRY Hedge Fund Activity: Q4 2015 in Review

151 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q4 2015, worth a combined $578M — down 11% from $653M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of ARRY and 23 opened new positions — a net loss of 5 holders — while 45 trimmed existing stakes and 48 added.

The largest buyer was Millennium Management, adding an estimated $11.1M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $23.5M sold.

  • 151 institutional investors held Array Biopharma Inc (ARRY) as of Q4 2015, down from 157 in Q3 2015.
  • Funds reported $578M of Array Biopharma Inc stock for Q4 2015, down 11% quarter-over-quarter.
  • 23 funds opened new Array Biopharma Inc positions in Q4 2015 and 28 closed out, a net change of -5 holders.
  • The largest Array Biopharma Inc buyer in Q4 2015 was Millennium Management, an estimated $11.1M added.
  • The largest Array Biopharma Inc seller in Q4 2015 was T. Rowe Price Associates, an estimated $23.5M sold.

Based on aggregated 13F filings for Q4 2015.